Ron Knockdown and Ron Monoclonal Antibody IMC-RON8 Sensitize Pancreatic Cancer to Histone Deacetylase Inhibitors (HDACi)
Figure 6
Mechanisms underlie IMC-RON8 sensitization of pancreatic cancer cells to Panobinostat.
A) Ron expression after co-treatment of Capan-1, L3.6pl and CFPAC-1 cells with IMC-RON8 and PS. B) Effect of co-treatment of IMC-RON8 and PS on pAkt and PARP cleavage. β-actin was used as a loading control.